Your browser doesn't support javascript.
loading
A case report of a cystic fibrosis patient with repeated isolation of Trichosporon mycotoxinivorans identified by a novel short-extraction method.
Goldenberger, Daniel; Hinic, Vladimira; Prince, Spasenija Savic; Tamm, Michael; Balestra, Anna-Maria; Hohler, Doris; Frei, Reno.
Afiliación
  • Goldenberger D; Division of Clinical Microbiology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland. daniel.goldenberger@usb.ch.
  • Hinic V; Division of Clinical Microbiology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Prince SS; Division of Pathology, University Hospital Basel, Schönbeinstrasse 40, CH-4031, Basel, Switzerland.
  • Tamm M; Division of Pneumology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Balestra AM; Division of Pneumology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
  • Hohler D; Present address: Division of Pneumology, St. Claraspital Basel, Basel, Switzerland.
  • Frei R; Division of Clinical Microbiology, University Hospital Basel, Petersgraben 4, CH-4031, Basel, Switzerland.
BMC Infect Dis ; 16(1): 601, 2016 Oct 25.
Article en En | MEDLINE | ID: mdl-27782810
ABSTRACT

BACKGROUND:

Trichosporon mycotoxinivorans is a recently described yeast-like fungal organism and its association as a pathogen for patients with cystic fibrosis (CF) was reported previously. We show the clinical course of a CF patient over 9 years as well as the applications of modern molecular and proteomic identification techniques of this rare fungus. CASE PRESENTATION We present the case of a 32-year-old male CF patient with sputum cultures continuously positive with the anamorphic yeast T. mycotoxinivorans during 9 years. Furthermore, susceptibility testing of T. mycotoxinivorans to different antifungals were performed. In addition, a rapid identification method of this novel fungal pathogen with matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) was applied using a simple extraction protocol.

CONCLUSIONS:

Our case presentation confirms T. mycotoxinivorans as a potential emerging pathogen in patients with CF. However, our CF patient showed mild symptoms over a very long time period of 9 years. A short MALDI-TOF MS procedure allows reliable and rapid identification of T. mycotoxinivorans and therefore should facilitate further study on the clinical relevance and epidemiology of this unusual fungal organism.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trichosporon / Fibrosis Quística Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Adult / Humans / Male Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2016 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trichosporon / Fibrosis Quística Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Adult / Humans / Male Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2016 Tipo del documento: Article País de afiliación: Suiza